Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Zhejiang Cheng Yi Pharmaceutical Co., Ltd

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 5Zhejiang Cheng Yi Pharmaceutical Co., Ltd.

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    FDA Audited

    USA
    ASPEN
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    ASPEN
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2025-03-07

    Zhejiang Cheng Yi Pharmaceutical Co., Ltd

    City : Wenzhou

    State :

    Country/Area : China

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2025-03-07

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    ASPEN
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    ASPEN
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2019-11-22

    Zhejiang Cheng Yi Pharmaceutical Co., Ltd

    City : Wenzhou

    State :

    Country/Area : China

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2019-11-22

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    ASPEN
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    ASPEN
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2016-07-15

    Zhejiang Cheng Yi Pharmaceutical Co., Ltd

    City : Wenzhou

    State :

    Country/Area : China

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2016-07-15

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    ASPEN
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    ASPEN
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2014-03-14

    Zhejiang Cheng Yi Pharmaceutical Co., Ltd

    City : Wenzhou

    State :

    Country/Area : China

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2014-03-14

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    FDA Audited

    USA
    ASPEN
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    ASPEN
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2010-09-09

    Zhejiang Cheng Yi Pharmaceutical Co., Ltd

    City : Wenzhou

    State :

    Country/Area : China

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2010-09-09

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Contact Zhejiang Cheng Yi Pharmaceutical Co., Ltd and get a quotation

    Zhejiang Cheng Yi Pharmaceutical Co., Ltd is a supplier offers 9 products (APIs, Excipients or Intermediates).

    Find a price of Azathioprine bulk with CEP offered by Zhejiang Cheng Yi Pharmaceutical Co., Ltd

    Find a price of Ribavirin bulk with CEP offered by Zhejiang Cheng Yi Pharmaceutical Co., Ltd

    Find a price of Azathioprine bulk with DMF offered by Zhejiang Cheng Yi Pharmaceutical Co., Ltd

    Find a price of Glucosamine Hydrochloride bulk with DMF offered by Zhejiang Cheng Yi Pharmaceutical Co., Ltd

    Find a price of Mercaptopurine bulk with DMF offered by Zhejiang Cheng Yi Pharmaceutical Co., Ltd

    Find a price of Ribavirin bulk with DMF offered by Zhejiang Cheng Yi Pharmaceutical Co., Ltd

    Find a price of Azathioprine bulk offered by Zhejiang Cheng Yi Pharmaceutical Co., Ltd

    Find a price of Capecitabine bulk offered by Zhejiang Cheng Yi Pharmaceutical Co., Ltd

    Find a price of Mercaptopurine bulk offered by Zhejiang Cheng Yi Pharmaceutical Co., Ltd

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.